Richard N. Gottfried
- Democratic
Primary
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
No votes to display
AMEND AND RECOMMIT TO HEALTH
PRINT NUMBER 7245A
REFERRED TO HEALTH
REFERRED TO HEALTH
| Bill Text Versions | Format |
|---|---|
| A7245 | PDF HTML |
| A7245A |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.